The UK’s CMOs have sought to reassure doctors about their decision to back a 12-week gap between COVID-19 vaccines as the vaccination programme shifts to providing as many people in at-risk groups as possible with a first dose of either the Pfizer/BioNTech or Oxford/AstraZeneca jabs.
